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(5), as evidenced by steeper temporal discounting rates, 
altered decision making, and an aversion to delay of grati-
fication in reward-related tests (6–9). Temporal discount-
ing is the patient’s preference to receive smaller rewards 
sooner rather than larger rewards later and is postulated 
to be an intermediate phenotype for impulsivity. Neuro-
imaging studies have shown engagement of alternative 
brain regions in decision making in ADHD patients (10). 
A prominent feature is hypoactivation of the ventral stria-
tum, a brain area with an important role in reward pro-
cessing (11, 12), during reward anticipation (13, 14). Ven-
tral striatal activity is also associated with impulsivity, a 
hallmark of ADHD (12, 13).
Recently, the NOS1 gene was identified as a candidate 
gene for ADHD and other impulsivity disorders (15). A 
variant in this gene was also among the top findings of a 
genome-wide association study in ADHD (3). NOS1 en-
codes nitric oxide synthase 1. Nitric oxide, the product of 
this enzyme’s activity, acts as the second messenger down-
stream of the N-methyl-d-aspartate receptor and interacts 
with both the dopaminergic and serotonergic systems in 
the human brain. Nitric oxide inhibits monoamine trans-
porters, thereby modulating the dopamine and noradren-
alin concentration in the extracellular space (16). In addi-
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O b je c t iv e :  Attention deficit hyperactiv-
ity disorder (ADHD) is a highly heritable 
disorder. The NOS1  gene encoding nitric 
oxide synthase is a candidate gene for 
ADHD and has been previously linked 
w ith impulsivity. In the present study, 
the authors investigated the effect of a 
functional variable number of tandem  
repeats (VNTR) polymorphism  in NOS1  
(NOS1  exon 1f-VNTR) on the processing 
of rewards, one of the cognitive deficits 
in ADHD.
M e tho d :  A  sample of 136 participants, 
consisting of 87 adult ADHD patients and 
49 healthy comparison subjects, com -
pleted a reward-related impulsivity task. 
A total of 104 participants also underwent 
functional magnetic resonance imaging 
during a reward anticipation task. The 
effect of the NOS1  exon 1f-VNTR geno-
type on reward-related impulsivity and 
reward-related ventral striatal activity was 
exam ined.
R e su lts :  ADHD patients had higher im -
pulsivity scores and lower ventral striatal 
activity than healthy comparison sub-
jects. The association between the short 
allele and increased impulsivity was con-
firmed. However, independent of disease 
status, homozygous carriers of the short 
allele of NOS1 , the ADHD risk genotype, 
demonstrated higher ventral striatal ac-
tivity than carriers of the other NOS1  
VNTR genotypes.
Co n c lu s io n s :  The authors suggest that 
the NOS1  genotype influences impulsiv-
ity and its relation w ith ADHD is mediated 
through effects on this behavioral trait. 
Increased ventral striatal activity related 
to NOS1  may be compensatory for effects 
in other brain regions.
Attention deficit hyperactivity disorder (ADHD) is 
a common neuropsychiatric disorder in childhood that 
often persists into adulthood. Approximately 15% of pa-
tients still meet full ADHD criteria according to DSM-IV 
in adulthood, and 40%–60% remit only partially and have 
increased symptom counts (1). Despite substantial heri-
tability, as shown by adoption and twin studies (2), iden-
tifying genes for ADHD has proven difficult (3, 4). Only 
a handful of susceptibility genes have been identified to 
date, all of which increase ADHD risk with only small ef-
fect sizes (4). This polygenic heritability—together with 
the heterogeneity of the ADHD clinical phenotype—is a 
complicating factor in the identification of ADHD genes. 
However, information on the function of those genes 
known to be associated with ADHD could help us identify 
the biological mechanisms underlying the disorder.
Understanding associations between genes and a com-
plex disorder like ADHD may be made easier if the disor-
der is decomposed into intermediate phenotypes such as 
neurocognitive measures. Conceivably, fewer genes will 
play a role in one of these intermediate neurocognitive 
phenotypes than in the entire clinical phenotype. Besides 
the well-known executive function problems, patients 
with ADHD often display abnormal sensitivity to reward 
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Exclusion criteria for participants were psychosis, alcohol or 
substance addiction in the last 6 months, current major depres-
sion (assessed using SCID-I), full-scale IQ estimate <70 (assessed 
using the Wechsler Adult Intelligence Scale-III), neurological dis-
orders, sensorimotor disabilities, non-Caucasian ethnicity, and 
medication use other than psychostimulants or atomoxetine. An 
additional exclusion criterion for healthy comparison subjects 
was a current or past neurological or psychiatric disorder accord-
ing to SCID-I. Twenty-eight patients were medication-naïve at 
the time of the trial. Patients who were receiving treatment with 
ADHD medication (methylphenidate [N=44], atomoxetine [N=4], 
and dextroamphetamine [N=11]) were asked to withhold use of 
their medication 24 hours prior to testing. As a result of exces-
sive movement during scanning (N=4), metal in the body or tat-
toos (N=25), and technical problems (N=3), the final sample size 
for the imaging part of the study was 104 (ADHD patients, N=63; 
healthy comparison subjects, N=41). This final sample included 
19 medication-naïve patients; 26 ADHD patients and 18 com-
parison subjects in this subsample were men. Participants had 
to refrain from smoking prior to and during testing (26). Indirect 
effects of smoking were controlled for by taking smoking habits 
(yes/no) into account in the analysis. This study was approved by 
the regional ethics committee. Written informed consent was ob-
tained from all participants.
Geno typ ing
Genotyping of the exon 1f-VNTR was performed by sequence-
length analysis on a genetic analyzer (see the data supplement 
accompanying the online version of this article). The resulting 
genotypes were converted to short (S) and long (L) alleles. The ho-
mozygous short allele (short-short [SS]) genotype has been iden-
tified as a risk factor for psychiatric disorders (15), and therefore 
genotypes were stratified into an SS carrier group and a group 
of participants carrying at least one long allele (short-long [SL]/
long-long [LL]) for the behavioral and functional data analyses.
Behav io ra l Ta sk : Rew a rd -Re la ted  Im pu lsiv ity
The delay discounting task (27) was administered to measure 
reward-related impulsivity. On each trial of this task, participants 
had to choose between varying amounts of hypothetical imme-
diate rewards and hypothetical delayed rewards. A total of 110 
questions (such as, “Which do you prefer: 30 euro 180 days from 
now or 2 euro now?”) were displayed on a screen. In successive 
questions, the amount of immediate money was increased until it 
equaled the delayed reward. This way, the personal point of indif-
ference, where two options have equal subjective value to an indi-
vidual, was determined for every participant. Indifference points 
were determined for three delayed reward conditions (10, 30, and 
100 euros) and five different delays (2, 30, 180, 365, and 730 days). 
By using a discount function, an impulsivity parameter (k) could 
be derived. Previous studies have shown that discounting curves 
fit well with hyperbolic functions (28). The discount function for 
the task was as follows: V=a/(1+kD). For this equation, “V” rep-
resents the present value of the delayed reward, in this case the 
indifference point, and “a” represents the delayed reward (10, 30, 
or 100 euro) at delay “D” (2, 30, 180, 365, or 730 days). Higher lev-
els of k correspond to steeper discounting rates and higher levels 
of impulsivity (29). The main outcome measure was the average 
k for 10 euro (k10), 30 euro (k30), and 100 euro (k100) and the aver-
age score of all trials (kall). A logarithmic transformation was per-
formed to normalize k values (log k).
Func tio na l M agne tic  Re sonance  Im ag ing  ( fM R I) 
R ew a rd  A n tic ipa tio n  Pa rad igm
To examine neural responses to reward anticipation, par-
ticipants were scanned while performing a modified monetary 
incentive delay task, which has been shown to induce ventral 
tion, NOS1 functions in neurite outgrowth, suggesting an 
early influence on brain development (17).
Located on chromosome 12, the NOS1 gene has a com-
plex structure, consisting of 28 protein coding exons, with 12 
alternative untranslated first exons referred to as exons 1a–
1l. In exon 1f, a variable number of tandem repeats (VNTR) 
polymorphism that alters gene expression is present (15). 
This exon has a relatively high expression in the brain, with 
high specificity for the basal ganglia, including the striatum. 
Since NOS1 modulates tonic extracellular dopamine levels 
and phasic dopaminergic neuron spike activity, it might af-
fect disorders with deficient striatal functioning (18). Tar-
geted disruption of Nos1 in mice increased impulsivity and 
aggressiveness, reduced anxiety, and impaired learning (19, 
20). Human behavioral and imaging studies have shown 
NOS1 exon 1f-VNTR to be associated with hyperactive, im-
pulsive, and aggressive behavior as well as hypofunctioning 
of the anterior cingulate cortex (15, 21, 22).
Although the NOS1 gene has been linked to ADHD, im-
pulsivity, and modification of neurotransmitter levels in the 
striatum, effects of NOS1 genetic variation on striatal activ-
ity have not been investigated. The objective of the present 
study was to better understand the effect of this gene on 
neurobiological dysfunctioning in adult ADHD by explor-
ing the influence of the exon 1f-VNTR on impulsivity and 
reward-related striatal activity in a large sample of adult 
ADHD patients (N=87) and healthy comparison subjects 
(N=49). Given the results of previous studies, we expected 
to find 1) higher impulsivity scores as well as 2) ventral 
striatal hypoactivation in ADHD patients relative to healthy 
comparison subjects, 3) increased impulsivity in homozy-
gous carriers of the NOS1 exon 1f-VNTR short allele, and 4) 
modulation of ventral striatal activity by the exon 1f-VNTR.
M ethod
Pa rtic ipan ts
One hundred and 36 individuals (adult ADHD patients, N=87; 
healthy comparison subjects, N=49) from the Dutch cohort of 
the International Multicenter persistent ADHD CollaboraTion 
(IMpACT [23]) participated in the present study. All participants 
underwent endophenotypic tests for adult ADHD in which cog-
nitive functioning and neuroimaging data were collected. The 
ADHD patients and an age-, gender-, and IQ-comparable group 
of healthy subjects were recruited from the department of Psychi-
atry of the Radboud University Nijmegen Medical Centre (Nijme-
gen, the Netherlands) and through advertisement. Patients were 
included if they met DSM-IV-TR criteria for ADHD in childhood 
as well as adulthood. All participants were assessed using the Di-
agnostic Interview for Adult ADHD (24). This interview focuses on 
the 18 DSM-IV symptoms of ADHD and uses concrete and realis-
tic examples to thoroughly investigate whether a symptom is cur-
rently present or was present in childhood. In order to obtain in-
formation about ADHD symptoms and impairment in childhood, 
additional information was acquired from parent and school 
reports whenever possible. The Structured Clinical Interview for 
DSM-IV (SCID-I) was used for comorbidity assessment. Assess-
ments were carried out by trained professionals (psychiatrists 
or psychologists). In addition, a quantitative measure of clinical 
symptoms was obtained using the ADHD Rating Scale-IV (25).
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and “miss” events in both the reward and no-reward conditions. 
These events were modeled as event-related regressors, with a 
zero duration, and convolved with the canonical hemodynamic 
response function in SPM5. Additionally, realignment param-
eters were included to account for movement-related variability, 
and time-derivatives were used, which resulted in 14 additional 
regressors of no interest. Data were high-pass filtered using a fre-
quency cutoff of 1/128 Hz.
To assess neural activity associated with reward anticipation, 
our contrast of interest concerned the reward and no-reward cue 
events. The contrast images for these events were submitted to a 
second-level random effect analysis, with the following full facto-
rial 2×2×2 design: ADHD status, NOS1 genotype, and cue (reward 
versus no-reward). Age and gender were included as covariates 
(31, 32). For the whole-brain analysis, the main effect of cue was 
tested using a threshold of p<0.05 (family-wise error-corrected) 
and a cluster size threshold of 35 voxels. Because of our a priori hy-
pothesis regarding the ventral striatum, the resulting suprathresh-
old ventral striatal region in the whole-brain analysis of the main 
effect of cue was defined as our region of interest. Defining this 
functional region for two groups with proven differential ventral 
striatal activity (such as ADHD patients and healthy comparison 
subjects [13, 14]) bears the risk of bias if the two groups are not 
equal in size (for details see reference 33). To prevent any selection 
bias in our study (in which the patient group was bigger), we sepa-
rately defined functional ventral striatal region for each diagnostic 
group and analyzed both groups to assess the effect of genotype. 
Cluster beta weights were extracted from these regions using the 
MarsBaR toolbox (34). To replicate previous studies on striatal 
hypoactivation in ADHD patients, a one-sided ANOVA was per-
formed, with ADHD status as an independent variable and ventral 
striatal activity as a dependent variable. Pearson’s correlations be-
tween ventral striatal activity and impulsivity were calculated. All 
statistical tests were two-sided, unless stated otherwise.
re su lts
Demographic characteristics of the study sample are pre-
sented in Table 1. There were no significant differences be-
tween groups based on ADHD status or NOS1 exon 1f-VNTR 
striatal activity (30) (see the data supplement). Participants were 
asked to respond as quickly as possible to a target by pressing 
a button. Prior to display of this target, a cue (duration: 3.5–8.5 
seconds) was given to indicate whether a reward could or could 
not be obtained. After each target response, the outcome was 
displayed. Participants could gain 1 euro in the reward condition 
and no money during the no-reward condition if they responded 
between 270 msec and 500 msec after target onset. This response 
window was individually adjusted (see the data supplement). The 
task consisted of a practice trial, after which the purpose of the 
task was again briefly summarized, followed by 50 trials in which 
reward and no-reward cues were randomly displayed. The experi-
ment lasted 12 minutes, and a total of 12 euro could be gained. At 
the end of the experiment, the awarded money was shown on the 
screen and transferred to the participant’s bank account. Reac-
tion times in the reward and no-reward condition were the be-
havioral outcome measures.
Behav io ra l A na ly sis
rew ard -re la te d  im pu ls iv it y. To assess the effects of ADHD sta-
tus (ADHD patients relative to healthy comparison subjects) and 
NOS1 genotype (SS versus SL/LL) on reward-related impulsivity, 
analyses of variance (ANOVAs) were carried out using log(k10), 
log(k30), log(k100), and log(kall) as dependent variables, and age 
and gender were incorporated as covariates. Cohen’s d was calcu-
lated to identify effect size.
M one ta r y  in cen tive  d e lay  ta sk . A repeated-measures general 
linear model was performed to assess the effect of cue (reward/
no-reward) on response time. This general linear model was car-
ried out with reaction time as the dependent variable and cue as 
the within-subject variable. The between-subject factors ADHD 
status and NOS1 exon 1f-VNTR genotype were added to the gen-
eral linear model to identify group effects of cue-induced reaction 
times. Cohen’s d was also calculated.
fM R I A na ly sis
After preprocessing (for details on fMRI acquisition and pre-
processing, see the data supplement), first-level analyses were 
performed for each participant to estimate eight parameters of 
interest with a general linear model for the “cue,” “target,” “hit,” 
tA ble  1 . D em og raph ic  Charac te ristic s  o f  A du lt A DHD  Pa tien ts  and  H ea lthy  Com parison  Sub je c ts  S tra tified  by  the  NOS1  
G eno type a
Characteristic
ADHD Patients Comparison Subjects
Genotype Genotype
SS Allele Carrier  
(N=16)
SL/LL Allele Carrier 
(N=71)
SS Allele Carrier  
(N=11)
SL/LL Allele Carrier 
(N=38)
Mean SD Mean SD Mean SD Mean SD
Age (years) 39.4 11.0 37.1 11.6 38.5 11.3 37.5 11.0
IQb 10.4 1.9 11.1 2.6 12.3 1.5 11.4 2.9
Inattentive symptoms 6.6 1.8 6.2 2.1 1.4 1.0 0.5 0.8
Hyperactive/impulsive symptoms 5.9 1.7 5.4 2.2 1.0 2.4 0.7 1.0
N % N % N % N %
Male 11 69 29 41 6 55 15 40
Medication naïve 7 43 21 30
LL homozygous 38 54 13 34
One or more current comorbid 
disorder(s)c 7 44 24 34
Eligible for functional magnetic 
resonance imaging 12 75 51 72 11 100 30 79
a Data for the short-short (SS), short-long (SL), and long-long (LL) genotypes of the NOS1 exon 1f-VNTR are shown; no deviation from Hardy-
Weinberg equilibrium was observed.
b Scores represent the average of the standard scores for the block design and vocabulary assessments of the Wechsler Adult Intelligence Scale-III.
c Disorders found more than once were mood and anxiety disorders (data for one participant are missing).
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were smokers, and smoking was equally distributed over 
the genotype groups (SS: 47%; SL/LL: 32%).
Behav io ra l R e su lts
rew ard -re la te d  im pu ls iv it y. ADHD patients showed high-
er levels of reward-related impulsivity than healthy com-
parison subjects on the delay discounting task (log(kall): 
F=7.15, df=1, 134, p=0.008). The strongest effect was found 
in the k100 condition in which the largest amount of mon-
ey (100 euro) was discounted (p<0.0001). Log(k100) was 
not significantly correlated with ADHD severity. In the 
ADHD group, patients with the SS genotype had higher 
reward-related impulsivity scores than those with SL/LL 
genotypes (F=4.73, df=1, 85, p=0.03, Cohen’s d=0.60) (Fig-
ure 1). In the comparison group, the effect of genotype did 
not reach significance. No interaction of diagnosis and 
genotype was observed. Within the ADHD group, impul-
sivity was not significantly correlated with ADHD severity 
(number of ADHD symptoms).
M od ifie d  m one ta r y  in cen tive  d e lay  ta sk . A main effect of 
cue on reaction time was found for the monetary incentive 
delay task (F=165.54, df=1, 104, p<0.0001). As expected, 
participants reacted faster in reward trials (mean response 
time: 243 msec) than in no-reward trials (mean response 
time: 284 msec) (Table 2). ADHD diagnosis, NOS1 geno-
type, or the interaction of both these factors did not affect 
cue-induced reaction time.
Func tio na l Im ag ing  Re su lts
Brain regions activated in the “reward cue>no-reward 
cue” contrast are shown in Figure 2 (also see the data sup-
plement). In the whole-brain analysis of the bilateral ven-
tral striatum, the lateral prefrontal cortex, insula, left puta-
men, and left middle frontal gyrus were activated. Further 
analysis focused on bilateral ventral striatal activity.
rew ard -re la ted  ven tra l s tria ta l ac tiv ity. Bilateral average 
cluster activity in the ventral striatum for both the patient 
and comparison groups is shown in Figure 2. ADHD patients 
had lower ventral striatal activity than healthy comparison 
subjects during reward anticipation (F=3.43, df=1, 102, 
p=0.03), confirming findings in previous studies (13, 14).
genotype with respect to gender, age, or IQ. ADHD patients 
and healthy comparison subjects showed the expected dif-
ferences in self-reported ADHD symptoms (p<0.001) and 
an equal distribution of not otherwise specified exon 1f-
VNTR genotype. Fifty-four patients fulfilled criteria for the 
combined ADHD subtype; 20 fulfilled criteria for the inat-
tentive subtype; and 13 were characterized as hyperactive/
impulsive. Within the patient group, medication use was 
equally distributed over the genotype subgroups (SS, SL/
LL), with no differences in disease severity between medi-
cated and never-medicated patients. A similar distribution 
of characteristics was observed in the subsample of par-
ticipants that underwent fMRI. In this subsample, 42% of 
ADHD patients and 24% of healthy comparison subjects 
fIGure  1 . Im pu lsiv ity  r a ting s on  the  D e lay  D iscoun ting  
task  fo r A du lt A DHD  Pa tien ts  and  H ea lthy  Com parison  
























a Scores were higher in the ADHD group than in the healthy com-
parison group (less negative values [i.e., smaller bars] for log(k100) 
represent higher impulsivity). Within the patient group, those with 
the homozygous short allele (SS) genotype had higher impulsivity 
scores than carriers of the short-long (SL) allele or long-long (LL) al-
lele (F=4.73, df=1, 85, p=0.03).
tA ble  2 . behav io ra l r e su lts  o f  the  M od ified  M one ta ry  In cen tive  D e lay  task  fo r A du lt A DHD  Pa tien ts  and  H ea lthy  Com -
parison  Sub je c tsa
Variable
ADHD Patients Comparison Subjects
Genotype Genotype
SS Allele Carrier 
(N=12)
SL/LL Allele Carrier 
(N=51)
SS Allele Carrier 
(N=11)
SL/LL Allele Carrier 
(N=30)
Mean SD Mean SD Mean SD Mean SD
Mean reaction time reward (msec) 240.2 31.7 245.7 33.6 233.1 29.5 246.3 35.1
Mean reaction time no reward (msec) 281.7 47.7 287.6 48.9 274.6 52.2 285.8 45.4
Hit rate reward 0.40 0.03 0.40 0.05 0.41 0.05 0.39 0.05
Hit rate no reward 0.37 0.06 0.35 0.07 0.35 0.07 0.35 0.06
a Data for the short-short (SS), short-long (SL), and long-long (LL) genotypes of the NOS1 exon 1f-VNTR are shown.
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ADHD patients and healthy comparison subjects), carri-
ers of the SS genotype showed higher activity than SL/LL 
genotype carriers (Figure 2).
Ventral striatal activity did not differ between medi-
cated and medication-naïve patients, nor was an effect of 
smoking observed among either patients or healthy com-
parison subjects.
The functional region of interest that was defined based 
on striatal activity observed in the ADHD group (Figure 
2) showed a significant effect of NOS1 genotype (F=4.75, 
df=1, 61, p=0.03, Cohen’s d=0.81); this same effect was seen 
in analysis based on the functional region of interest de-
fined by activity in healthy comparison subjects (F=11.45, 
df=1, 39, p=0.002, Cohen’s d=1.03). For both definitions (in 
fIGure  2 . Ven tra l S tria ta l A c tiv a tion  in  re spon se  to  rew ard -re la ted  Cue  even ts in  A du lt A DHD  Pa tien ts  and  H ea lthy  Com -

























































































































a The whole-brain analysis (A) (y=6, z=–4, p<0.05 [family-wise error-corrected]) of main effect of reward anticipation (“reward cue>no-reward 
cue” contrast) showing bilateral ventral striatal and frontal activity is depicted; the color bar represents T values. The mean beta weights (B) 
of the bilateral ventral striatum during the reward anticipation task for ADHD patients and healthy comparison subjects are shown. ADHD 
patients demonstrated hypoactivation of the ventral striatum relative to healthy comparison subjects. The bilateral ventral striatal functional 
regions of interest (C) are displayed, as defined based on the activity patterns observed in both diagnostic groups (at y=10, p=0.0005, un-
corrected) (ADHD group [blue]: cluster size: left, 315 voxels, right, 151 voxels; healthy comparison group [red]: cluster size: left, 990 voxels, 
right, 1,440 voxels). The mean beta weights of the bilateral ventral striatum during the reward anticipation task for the ADHD and healthy 
comparison groups stratified by NOS1 exon 1f-VNTR genotype (D) are depicted; results showed a genotype effect in both diagnostic groups, 
with the short-short genotype having higher striatal activation.
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What appears discordant is the combination of in-
creased ventral striatal activity in more impulsive healthy 
individuals with the reduced reward-related ventral stria-
tal activity and no significant correlation with impulsiv-
ity in patients with ADHD, a disorder for which increased 
impulsivity is a hallmark (12, 13). For healthy individuals, 
our findings match those of an earlier study conducted 
by Hariri et al. (35), where impulsivity as measured by the 
delay discounting task was found to be positively corre-
lated with ventral striatal activity. However, earlier studies 
with sample sizes smaller than that of our study reported a 
negative association in ADHD patients (13, 14).
Given the differences in findings for ventral striatal ac-
tivity in ADHD patients and healthy individuals, one might 
have expected to observe a differential NOS1 genotype ef-
fect in the two groups or a gene-by-disorder interaction, 
as Durston et al. (37) found for the DAT1 gene. However, 
the finding of NOS1 genotype effects in the same direc-
tion in both groups shows that the NOS1 exon 1f-VNTR SS 
genotype related to ADHD does not contribute to ventral 
striatal hypoactivation in the disorder but acts on reward-
related impulsivity. Thus, the ventral striatal hypoactiva-
tion in ADHD must be caused by something other than 
the NOS1 gene. One could consider altered baseline do-
pamine levels in the striatum in ADHD (38) as a possible 
explanation, since positive correlations between striatal 
dopamine and ventral striatal activity exist in healthy sub-
jects (39). In addition, the influence of other ADHD candi-
date genes such as the dopamine transporter gene (DAT1/
SLC6A3) (40), which is also associated with altered dopa-
minergic synthesis—or perhaps an altered connectivity 
between the prefrontal cortex and striatum (41)—might 
play a role. Thus, one might hypothesize that the reduced 
ventral striatal activity is a compensatory mechanism to 
alleviate the effects of reduced prefrontal control.
Combined consideration of intermediate phenotypes, 
neurobiological mechanisms, and molecular genetic ef-
fects may therefore elucidate mechanisms contributing 
to the clinical symptoms of ADHD more completely than 
the analysis of any of these parameters in isolation. Con-
sistent with these expectations, functional effects of the 
NOS1 exon 1f-VNTR genotype were more readily observed 
(i.e., higher effect size) in brain activity (Cohen’s d range: 
0.8–1.0) than at the behavioral level (Cohen’s d range: 0.3–
0.6), in accordance with the view that the former is more 
proximal to genes. Dissecting the clinical ADHD pheno-
type into relevant, measurable traits such as motivational 
deficits and assessing genetic effects on these traits on a 
neurobiological level are necessary steps to elucidate the 
biological mechanisms underlying the disorder.
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Co rre la tio n  b e tw e en  ven tra l s tr ia ta l a c tiv it y  and  im pu l-
s iv it y. The correlation between ventral striatal activity 
and impulsivity in healthy comparison subjects (r=0.31, 
p=0.04) was significantly different (p=0.04) from the cor-
relation in ADHD patients (Figure 3).
D iscu ssion
The NOS1 exon 1f-VNTR genotype influenced reward 
cue-related ventral striatal activity in the participants of 
this study, with the same direction of effect in both the 
ADHD and comparison groups. Genotype also modulated 
reward-related impulsivity levels in ADHD patients. The 
effect of the NOS1 genotype on reward-related impulsivity 
in the healthy comparison group was similar but did not 
reach statistical significance. A smaller subgroup with the 
short allele (N=11) may account for this failure to detect 
significance. The observed association of the NOS1 geno-
type with reward-related impulsivity in ADHD patients 
replicates earlier findings in patients with impulse-control 
disorders compared with healthy subjects (21, 22). Our re-
sults now extend the effect of the NOS1 genotype to ven-
tral striatal activity, a critical component of the underlying 
neurological substrate of impulsivity (35).
The role of NOS1 in reward-related impulsivity, ob-
served in the behavioral analysis of this study as well as in 
several psychiatric disorders and the general population 
(3, 15, 22, 36), suggests that the association of this gene 
with clinical phenotypes such as ADHD is mediated by its 
effect on this behavioral trait. Additionally, our finding that 
the genotype subgroup linked with higher reward-related 
impulsivity is associated with higher activity of the ven-
tral striatum (which is consistent with previous research 
[35]) corroborates NOS1’s role in impulsivity, since we now 
show that reward-cue-related impulsivity is positively cor-
related with ventral striatal activity in healthy subjects.
fIGure  3 . Co rre la tion  be tw een  Ven tra l S tria ta l A c tiv a tion  
and  Im pu lsiv ity  in  A du lt A DHD  Pa tien ts  and  H ea lthy  Com -
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a The scatterplot depicts the correlation between reward-related im-
pulsivity scores (log[k100]) and ventral striatal activity.
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